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Clinical data are routinely collected as part of patient care or for 
administrative and funding purposes. This information is often 
stored digitally and is therefore relatively easy to analyse. Studies 
based on these analyses may provide useful insights to complement 
formal clinical trials and contribute to our scientific knowledge base.[1] 
However, these are observational data and prone to various errors 
and biases, which may undermine the usefulness and generalisability 
of any information produced. The size of the database does not 
guarantee reliability – even extremely large datasets, so-called ‘big 
data’, are at risk.[2] 
Observational data can reflect the ‘real world’. For example, the 
efficacy and toxicity of a drug are initially evaluated in the setting 
of a clinical trial. Observational data may be useful in larger and 
more diverse populations of daily practice. These data can give a 
better sense of the overall effectiveness of a drug and also lead to 
the identification of rare adverse effects that may not be seen in a 
randomised trial. Observational studies may also reveal associations 
and possible links between diseases and aetiological or prognostic 
factors, which might be explored and defined in more planned and 
targeted studies. 
However, observational studies based on routine data are more 
prone to error and bias than planned prospective observational 
studies. Routine datasets would have been designed for a specific 
purpose and might not include key variables, which would be 
important for a prognostic or comparative study but are not relevant 
to the primary purpose of the dataset. Also, they may not have 
undergone the same verification and quality assurance as formal 
planned clinical studies and trials and perhaps be more at risk of 
coding and transcription errors. 
Observational data will also be susceptible to bias, which may be 
technical or cognitive in nature.[3] An example of technical bias is 
when the reason for selecting a patient for an intervention is unclear 
and may depend on unknown or unrecorded prognostic factors. 
An example of cognitive bias is the tendency to look for results that 
confirm our prior beliefs. Large datasets cannot be assumed to be less 
susceptible to bias than smaller sets.[2]
Against this background, an international group of more than 100 
scientists and stakeholders produced a statement and a checklist on 
reporting of routinely collected clinical data. The statement is referred 
to as the RECORD statement (REporitng of studies Conducted using 
Observational Routinely-collected health Data) (https://www.record-
statement.org/checklist.php).[4]
The RECORD statement is an extension of a previous statement 
for using observational data in epidemiological studies, called 
STROBE (Strengthening the Reporting of Observational Studies in 
Epidemiology).[5] This statement has been widely used and endorsed 
by medical journals. 
The RECORD checklist contains items on the title, abstract, 
introduction, methods, results and discussion in manuscripts. 
Although all the items on the checklist need to be noted, selected key 
items are the following:
Introduction. Item 3: state specific study objectives, including any 
prespecified hypotheses. The authors should clarify whether the 
study was exploratory and aimed at finding new associations in the 
data or aimed at confirming whether the data were compatible with 
existing hypotheses. It is not sufficient to simply refer to the data as 
descriptive.
Methods. Item 4: the key elements of study design should be 
presented. Item 7: describe the variables that might have modified the 
observed effects. Item 9: describe how potential bias was addressed. 
Item 12: describe the statistical methods used and how missing data 
were addressed.
Results. Item 13.1: describe the selection of persons included in the 
study, including patients excluded because of poor data quality and 
data availability.
Discussion. Item 19: discuss limitations of the study, considering 
potential bias or possible inaccurate data. Item 19.1: discuss the 
implications of using data that were not created or collected to answer 
the specific research questions. This would include unmeasured 
confounding factors, missing data and changing eligibility over time. 
While adherence to the RECORD statement and checklist offers 
useful insights, observational studies from routinely collected data 
have inherent scientific limitations. These will need to be considered 
within the context of formal clinical studies and other reporting 
guidelines.[6] 
An important limitation is that economically and socially 
vulnerable groups may be under-represented in observational studies 
based on the database population. 
The effectiveness of interventions also cannot be reliably deduced 
from observational data alone, unless the effect is large, it has a clear 
mechanistic explanation and the interval between intervention and 
outcome is short.[7] Nonetheless, there may be important confounders 
that outweigh the effect of interventions. For example, the long 
survival of patients with early-stage prostate cancer may depend 
more on natural history than on any intervention. 
The RECORD statement and checklist 
should be used for the publication of 
observational studies using routinely 
collected observational data. 
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